During the past decade, Memorial Cancer Institute at Memorial Regional Hospital conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 59 clinical trials were completed, i.e. on average, 196.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 20 clinical trials were completed. i.e. 181.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Cancer Institute at Memorial Regional Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 40 trials, followed by "Children's Oncology Group" with 11 trials sponsored, "Pfizer" with 10 trials sponsored, "Bristol-Myers Squibb" with 6 trials sponsored and "Novartis Pharmaceuticals" with 6 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Cancer Institute at Memorial Regional Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 72 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Cancer Institute at Memorial Regional Hospital" are "Breast Cancer" (21 trials), "Lung Cancer" (16 trials), "Lymphoma" (10 trials), "Colorectal Cancer" (7 trials) and "Leukemia" (7 trials). Many other conditions were trialed in "Memorial Cancer Institute at Memorial Regional Hospital" in a lesser frequency.

Most popular intervention types in "Memorial Cancer Institute at Memorial Regional Hospital" are "Drug" (119 trials), "Biological" (31 trials), "Radiation" (19 trials), "Procedure" (16 trials) and "Other" (15 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (13 trials), "radiation therapy" (13 trials), "cisplatin" (12 trials), "Placebo" (10 trials) and "doxorubicin hydrochloride" (10 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Cancer Institute at Memorial Regional Hospital" are 113 trials for "All" genders, 20 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Memorial Cancer Institute at Memorial Regional Hospital". undefined are not yet recruiting, 9 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 94 completed trials in Memorial Cancer Institute at Memorial Regional Hospital, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Cancer Institute at Memorial Regional Hospital, 11 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".